Shareholders on Wednesday approved the combination of Irvine-based Cardiac Science Inc. and Bothell, Wash.-based Quinton Cardiology Systems Inc.
The companies expect to close the deal on Thursday.
Cardiac and Quinton struck a pact to combine in February. The deal calls for Quinton shareholders to get three-quarters of a share in the new company for each share of Quinton stock they own, while Cardiac shareholders would get a tenth of a share in the new company for their stakes.
Orange County is set to lose a corporate headquarters when the deal closes. The combined company’s base is moving to Bothell, a Seattle suburb, though it will keep the Cardiac name. The company plans to keep some research and development workers in Lake Forest.
Shares of Cardiac, which makes heart defibrillators, were unchanged in afterhours trading at $1.11 a share.
